In vitro effect of danazol on endometrioma cells in culture

The Journal of reproductive medicine · 2014 · vol. 59(1-2) , pp. 13–6 · PMID:24597280 · W116506007
Lab / animal OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-06-09 ⓘ

Danazol significantly decreased endometrioma cell proliferation in culture, inducing apoptosis and necrosis, demonstrating a direct effect on these cells.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

OBJECTIVE: To evaluate the effect of danazol on endometrioma cells in culture, in relation to cell proliferation. STUDY DESIGN: Danazol has been shown to be effective in treating endometriosis, leading to remission. The mode of action is through suppression of gonadotropins. A direct effect on endometriosis implants has been suggested. This study was conducted on endometrioma cell lines using various concentrations of danazol in ethanol solution. RESULTS: Danazol showed a decrease in proliferation ofendometrioma cells in culture. This was also associated with an increase in apoptosis and necrosis ofcultured cells. CONCLUSION: This study demonstrates the direct effect of danazol on endometrioma cells in culture.

My notes (saved in your browser only)

Condition tags

endometriosisendometrioma

MeSH descriptors

Cell Proliferation Danazol Endometriosis Estrogen Antagonists Apoptosis Apoptosis Apoptosis Cell Proliferation Cell Proliferation Cells, Cultured Cells, Cultured Danazol Danazol Danazol Dose-Response Relationship, Drug Dose-Response Relationship, Drug Endometriosis Endometriosis Estrogen Antagonists Estrogen Antagonists

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

europepmc
last seen: 2026-10-20T06:13:28.455750+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-10-08T21:13:21.326790+00:00
License: CC0 · commercial use OK